IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Squadron Capital Management LLC

Portfolio Profile

CIK: 0002050709 | OAK BROOK, IL

Investment Profile

Style

Deep Value

Turnover

Very High

Orientation

Concentrated trader
$292.1M
AUM
34
Positions
73.03%
Top 10 Conc.
96.9%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Relmada Therapeutics Inc(RLMD)7,350,000$50.9M15.78%
2C4 Therapeutics Inc(CCCC)7,200,000$33.6M10.43%
3Cogent Biosciences Inc(COGT)865,000$33.5M10.39%
4Kodiak Sciences Inc(KOD)500,000$19.5M6.05%
5Relay Therapeutics Inc(RLAY)970,000$18.1M5.63%

Sector Allocation

Latest filing, equity positions only

Healthcare93.24% · $272.3M
Unclassified6.76% · $19.7M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare95.54%93.24%-2.3%
Unclassified4.46%6.76%+2.3%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$236.0M | 33 pos.
$272.9M | 37 pos.
$322.2M | 43 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

24
New
18
6
Zentalis Pharmaceuticals Inc(ZNTL)
3,700,000
$17.9M
5.57%
7Edgewise Therapeutics Inc(EWTX)290,000$11.8M3.66%
8Maze Therapeutics Inc(MAZE)335,000$10.0M3.10%
9Inventiva SA(IVA)2,435,000$9.2M2.86%
10Adlai Nortye LTD(ANL)764,876$8.8M2.73%
Cap SizePrev %Curr %Change
Small Cap46.66%46.65%-0.01%
Micro Cap19.87%26.3%+6.43%
Mid Cap29%20.29%-8.71%
Unclassified4.46%6.76%+2.3%
Closed
11
Increased
6
Decreased
2
Unchanged